196 related articles for article (PubMed ID: 25924666)
1. Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement.
Sonmez A; Haymana C; Aydogdu A; Tapan S; Basaran Y; Meric C; Baskoy K; Dinc M; Yazici M; Taslipinar A; Barcin C; Yilmaz MI; Bolu E; Azal O
Endocr J; 2015; 62(7):605-13. PubMed ID: 25924666
[TBL] [Abstract][Full Text] [Related]
2. Effect of testosterone replacement therapy on vitamin D and FGF-23 levels in congenital hypogonadism.
Haymana C; Sonmez A; Aydogdu A; Tapan S; Basaran Y; Meric C; Baskoy K; Taslipinar A; Yilmaz MI; Azal O
Endokrynol Pol; 2017; 68(3):311-616. PubMed ID: 28230890
[TBL] [Abstract][Full Text] [Related]
3. Visceral adiposity index and triglyceride/high-density lipoprotein cholesterol ratio in hypogonadism.
Haymana C; Sonmez A; Aydogdu A; Tapan S; Basaran Y; Meric C; Baskoy K; Dinc M; Yazici M; Taslipinar A; Barcin C; Yilmaz MI; Bolu E; Azal O
Arch Endocrinol Metab; 2017; 61(3):282-287. PubMed ID: 28225990
[TBL] [Abstract][Full Text] [Related]
4. Increased Endothelial Dysfunction and Insulin Resistance in Patients with Klinefelter Syndrome.
Haymana C; Aydogdu A; Demirci I; Dinc M; Demir O; Torun D; Yesildal F; Meric C; Basaran Y; Sonmez A; Azal O
Endocr Metab Immune Disord Drug Targets; 2018; 18(4):401-406. PubMed ID: 29468986
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism.
Sonmez A; Haymana C; Bolu E; Aydogdu A; Tapan S; Serdar M; Altun B; Barcin C; Taslipinar A; Meric C; Uckaya G; Kutlu M
Eur J Endocrinol; 2011 May; 164(5):759-64. PubMed ID: 21325471
[TBL] [Abstract][Full Text] [Related]
6. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride-glucose index levels in patients with congenital hypogonadotropic hypogonadism and the relationship with endothelial dysfunction and insulin resistance.
Demirci I; Haymana C; Candemir B; Meric C; Yuksel B; Eser M; Akın O; Akın S; Ersoz Gulcelik N; Sonmez A
Endokrynol Pol; 2021; 72(3):232-237. PubMed ID: 33749808
[TBL] [Abstract][Full Text] [Related]
8. Trace Element Levels in Congenital Hypogonadotrophic Hypogonadism.
Aydogdu A; Haymana C; Soykut B; Erdem O; Basaran Y; Baskoy K; Dinc M; Taslipinar A; Sonmez A; Bolu E; Azal O
Biol Trace Elem Res; 2016 May; 171(1):26-32. PubMed ID: 26343359
[TBL] [Abstract][Full Text] [Related]
9. Effect of testosterone replacement therapy on insulin sensitivity and body composition in congenital hypogonadism: A prospective longitudinal follow-up study.
Reddy KC; Yadav SB
J Postgrad Med; 2021; 67(2):67-74. PubMed ID: 33942770
[TBL] [Abstract][Full Text] [Related]
10. HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism.
Bolu E; Sonmez A; Tapan S; Taslipinar A; Aydogdu A; Meric C; Basaran Y; Uckaya G; Serdar M; Kurt I; Azal O
Horm Metab Res; 2013 Jun; 45(6):443-8. PubMed ID: 23613012
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Gonadotropin Replacement Therapy on Metabolic Parameters and Body Composition in Men with Idiopathic Hypogonadotropic Hypogonadism.
Bayram F; Elbuken G; Korkmaz C; Aydogdu A; Karaca Z; Cakır I
Horm Metab Res; 2016 Feb; 48(2):112-7. PubMed ID: 26485362
[TBL] [Abstract][Full Text] [Related]
12. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
Tripathy D; Shah P; Lakshmy R; Reddy KS
Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
[TBL] [Abstract][Full Text] [Related]
13. [Testosterone replacement in hypogonadotropic hypogonadal young male improves insulin sensitivity].
Mao JF; Wu XY; Li NS; Lu SY; Jing ZM; Shi YF
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2550-2. PubMed ID: 19080648
[TBL] [Abstract][Full Text] [Related]
14. Relation between androgens and cardiovascular risk factors in a young population.
Gannagé-Yared MH; Chedid R; Abs L
Clin Endocrinol (Oxf); 2011 Jun; 74(6):720-5. PubMed ID: 21521259
[TBL] [Abstract][Full Text] [Related]
15. Osteoprotegerin, fibroblast growth factor 23, and vitamin D3 levels in male patients with hypogonadism.
Meric C; Sonmez A; Aydogdu A; Tapan S; Haymana C; Basaran Y; Baskoy K; Sertoglu E; Taslipinar A; Bolu E; Azal O
Horm Metab Res; 2014 Dec; 46(13):955-8. PubMed ID: 25181418
[TBL] [Abstract][Full Text] [Related]
16. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial.
Khripun I; Vorobyev S; Belousov I; Kogan M; Zitzmann M
Aging Male; 2019 Dec; 22(4):241-249. PubMed ID: 30235049
[TBL] [Abstract][Full Text] [Related]
17. [Impact of androgen therapy on metabolic and inflammatory profiles in male hypogonadism].
Chaabouni K; Naifar M; Mejdoub N; Lahyani A; Messedi M; Elleuch A; Turki M; Jamoussi K; Abid M; Ayedi F
Ann Biol Clin (Paris); 2014; 72(6):731-4. PubMed ID: 25486669
[TBL] [Abstract][Full Text] [Related]
18. Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism.
Naharci MI; Pinar M; Bolu E; Olgun A
Endocr Pract; 2007 Oct; 13(6):629-35. PubMed ID: 17954419
[TBL] [Abstract][Full Text] [Related]
19. [Testosterone replacement therapy improves metabolic indexes of the patients with hypogonadism: A meta-analysis].
Wang W; Wu J; Fan YF; Yang ZP; Zhu W; Yang GT; He JB
Zhonghua Nan Ke Xue; 2022 Oct; 28(10):926-934. PubMed ID: 37838960
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress status in congenital hypogonadism: an appraisal.
Haymana C; Aydoğdu A; Soykut B; Erdem O; Ibrahimov T; Dinc M; Meric C; Basaran Y; Sonmez A; Azal O
Toxicol Mech Methods; 2017 Jul; 27(6):451-457. PubMed ID: 28413915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
